Asthma is a common inflammatory disease of the lungs characterized by reversible airway obstruction, bronchial hyper-responsiveness, and chronic airway inflammation (1). The most widely used therapies for asthma include inhaled corticosteroids and bronchodilators (short- or long-acting β 2 -adrenergic agonists or muscarinic antagonists). Although most patients with asthma respond well to inhaled corticosteroids, asthma control is poor in some patients who require maximal dosages (2).
CITATION STYLE
Yang, B., Choi, H., Kim, S.-H., Yoon, H. J., & Lee, H. (2019). How will nanotechnology lead to better control of asthma? Annals of Translational Medicine, 7(20), 515–515. https://doi.org/10.21037/atm.2019.09.129
Mendeley helps you to discover research relevant for your work.